Advantages
DELpro solution provides a one-stop service from target to hit series. Our extended platform enables overall planning and management of protein production, DEL library production, affinity selection, data analysis, hit validation and structural biology for further optimization.
Screened Target Number via DEL
Total
Target
No. 279
Target class
13
*Binder
Confirm Rate
>90%
Strongest
Hit (KD)
pM
New Modality
Irreversible Covalent Screening
  • Specially designed library collection with electrophilic warheads
  • Optimized selection method to enhance the signal-to-noise ratio
RNA Target
  • Optimized selection procedure to counter charge, RNA/DNA interaction and structural integrity of RNA during DEL screen
DEL+ML
  • Ligand-based Virtual Screening
  • Lead-like Chemical Space
  • Cost-effective Compound Acquisition
Ready to start your project at HitS?
WuXi AppTec HitS unit provides one-stop Target-to-Hit services that enable companies in the pharmaceuticals, biotech, and academics worldwide to seek premium drug discovery.
Contact Us
HitS_service@wuxiapptec.com
DEL_service@wuxiapptec.com
US: +1 (857) 500-0235
China: +86 (021) 2066-3521
Online inquiry
  • WuXi AppTec China
    240 Hedan Road, Shanghai 200131, China
    1318 Wuzhong Avenue, Suzhou 215104, China
  • WuXi AppTec US
    Suite 111, 22 Strathmore Road Natick
    MA 01760-2434, USA
  • Crelux GmbH, a WuXi AppTec Company
    Am Klopferspitz 19a
    82152 Martinsried, Germany
Copyright © 2020 WuXi AppTec, All Rights Reserved.